Glycolipid antigen-presentation by CD1d and mechanism of NKT cell activation

被引：0
|
作者：
Zajonc, Dirk [1 ,2 ]
机构：
[1] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA
[2] Univ Ghent, Dept Internal Med, Ghent, Belgium
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
51
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeted disruption of CD1d prevents NKT cell development in pigs
    Yang, Guan
    Artiaga, Bianca L.
    Hackmann, Timothy J.
    Samuel, Melissa S.
    Walters, Eric M.
    Salek-Ardakani, Shahram
    Driver, John P.
    MAMMALIAN GENOME, 2015, 26 (5-6) : 264 - 270
  • [22] CD1d expression and invariant NKT cell responses in herpesvirus infections
    Chung, Brian K.
    Priatel, John J.
    Tan, Rusung
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [23] Bcl-xL Regulates CD1d-Mediated Antigen Presentation to NKT Cells by Altering CD1d Trafficking through the Endocytic Pathway
    Subrahmanyam, Priyanka B.
    Carey, Gregory B.
    Webb, Tonya J.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (05): : 2096 - 2105
  • [24] The length of lipids bound to human CD1d molecules modulates the affinity threshold of NKT cell activation
    McCarthy, Corinna
    Shepherd, Dawn
    Fleire, Sebastian
    Stronge, Victoria S.
    Koch, Michael
    Illarionov, Petr A.
    Bossi, Giovanna
    Salio, Mariolina
    Denkberg, Galit
    Reddington, Faye
    Tarlton, Andrea
    Reddy, B. Gopal
    Schmidt, Richard R.
    Reiter, Yoram
    Griffi, Gillian M.
    van der Merwe, P. Anton
    Besra, Gurdyal S.
    Jones, E. Yvonne
    Batista, Facundo D.
    Cerundolo, Vincenzo
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05): : 1131 - 1144
  • [25] CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor
    Natalie A. Borg
    Kwok S. Wun
    Lars Kjer-Nielsen
    Matthew C. J. Wilce
    Daniel G. Pellicci
    Ruide Koh
    Gurdyal S. Besra
    Mandvi Bharadwaj
    Dale I. Godfrey
    James McCluskey
    Jamie Rossjohn
    Nature, 2007, 448 : 44 - 49
  • [26] Enhancement of dendritic cell therapy for malignancy by co-activation of CD1d, restricted NKT cells, NK cells, and antigen CTL.
    Hagi, Tomomi
    Truong, Vy
    So, Hang-Fai
    Wang, Qiao
    Morley, Jacqueline S.
    Nieda, Mie
    Nicol, Andrew
    BLOOD, 2006, 108 (11) : 390B - 390B
  • [27] Function of human invariant NKT cells is regulated by the distinct binding kinetics of their TCRs to the CD1d/glycolipid complexes
    Matulis, G.
    Jacobsen, B.
    Villiger, P. M.
    Gadola, S. D.
    JOINT BONE SPINE, 2007, 74 (02) : 216 - 216
  • [28] Understanding and exploiting the NKT:CD1d system in disease
    Exley, M.
    IMMUNOLOGY, 2014, 143 : 15 - 15
  • [29] Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation
    Joshi, Sunil K.
    Lang, Gillian A.
    Devera, T. Scott
    Johnson, Amy M.
    Kovats, Susan
    Lang, Mark L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (05) : 783 - 790
  • [30] A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
    Kjer-Nielsen, L
    Borg, NA
    Pellicci, DG
    Beddoe, T
    Kostenko, L
    Clements, CS
    Williamson, NA
    Smyth, MJ
    Besra, GS
    Reid, HH
    Bharadwaj, M
    Godfrey, DI
    Rossjohn, J
    McCluskey, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03): : 661 - 673
12345